Search Results for: obinutuzumab

Gazyva (Obinutuzumab)

Gazyva (obinutuzumab) is a monoclonal antibody developed by Roche to treat people with follicular lymphoma, the most common type of slow-growing non-Hodgkin’s lymphoma. It is used in combination with the ... Read more

TGR-1202 (Umbralisib)

TGR-1202 (umbralisib) is an investigational therapy being developed by TG Therapeutics for the treatment of several hematologic cancers (cancers which form in the blood or immune system) and autoimmune diseases (diseases ... Read more